Article Text

Download PDFPDF
Investigation of the child with permanent hearing impairment
  1. Breege Mac Ardle1,
  2. Maria Bitner-Glindzicz2
  1. 1Nuffield Hearing and Speech Centre, Royal National Throat, Nose and Ear Hospital, London WCIX 8DA, UK
  2. 2Clinical and Molecular Genetics Unit, Great Ormond Street Hospital and Institute of Child Health, London WC1N 3JH, UK
  1. Dr Breege Mac Ardle, Nuffield Hearing and Speech Centre, Royal National Throat, Nose and Ear Hospital, 330 Gray’s Inn Road, London WCIX 8DA, UK; breege.macardle{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


In England the birth prevalence of bilateral per manent childhood hearing impairment (PCHI) of >40 dB HL is approximately 1:1000 live births but almost doubles up to the age of 9 years.1 The latter is accounted for by cases of PCHI that were not screened as part of the Newborn Hearing Screening Programme (NHSP) or were false nega tives, as well as children with acquired hearing loss and those with late onset or progressive deafness. In some areas the prevalence can be two to three times this figure.2 About 40% of children with PCHI have additional health or developmental problems, and about 20% of this population have more than two problems.3 In the developed world, at least 50% of PCHI has a genetic aetiology with environmental causes (which may include adverse perinatal factors, for example, extreme prematurity, hyperbilirubinaemia, aminoglycoside drugs, hypoxia, meningitis and congenital infections) and head trauma accounting for a further 25%. In the remaining 25% no cause for the deafness is found following aetiological investigation.4

The Importance of Aetiological Investigation of Deafness

A number of events have influenced how and when the aetiology of PCHI should be investigated. These include the introduction of the NHSP and its quality assessment programme which includes a standard that relates to implementation of best practice in aetiological investigation of deafness. Each local NHSP screening site has a lead clinician who is responsible for the aetiological investigation.5 Training for lead clinicians in aetiological investigation is provided by the NHSP.

Advances in the field of molecular genetics have also had a major impact which will continue in the future with “next generation” sequencing technologies. Advances in inner ear imaging techniques have also contributed significantly to aetiological investigation of many cases of PCHI. Research into the contribution of both symptomatic and asymptomatic cytomegalovirus (CMV) infection to PCHI …

View Full Text


  • Funding We are grateful to Dr Tim Beale for images and to Dr Kaukab Rajput and Sarita Fonesca who were contributors to the BAAP/BAPA guidelines.

  • Competing interests BMA and MB-G were members of the BAAP/BAPA group who wrote the guidelines on investigation of severe to profound deafness in children.

  • Provenance and peer review Commissioned; not externally peer reviewed.